Necrolytic Migratory Erythema
Necrolytic migratory erythema (NME) is a rare and highly distinctive paraneoplastic skin syndrome. It is regarded as the classic clinical clue to a pancreatic glucagonoma, a neuroendocrine tumor (NET) arising from the alpha cells of the islets of Langerhans. In more than 70% of patients who present with NME, the rash is directly linked to an advanced malignant glucagonoma, often with liver metastases already present at diagnosis.
At the molecular level, NME results from markedly raised blood glucagon (usually above 500 pg/mL, five to ten times normal). Excess glucagon drives intense protein breakdown, leading to severe depletion of serum amino acids, zinc (Zn) and essential fatty acids. Starved of these nutrients, keratinocytes in the upper epidermis undergo necrosis (superficial epidermal necrosis), triggering a persistent, migrating inflammatory dermatitis.
At Haute-Derma, we treat recognition of NME as potentially lifesaving. An accurate diagnosis of this rash sets off the search for a hidden pancreatic tumor, so patients can reach surgery or targeted therapy within the critical treatment window.
Clinical Features and the 4D Glucagonoma Syndrome
NME lesions follow a characteristic migrating cycle with distinct stages:
- Lesion Cycle (10–14 Days):
- Onset: burning red papular patches with irregular borders appear in skin folds (groin, buttocks, perianal area, thighs), at pressure points or around body openings (mouth, eyes).
- Progression: vesicles, shallow blisters and pustules soon form in the center. These rupture into raw, necrotic, weeping erosions that crust over with reddish-brown scabs.
- Healing and migration: the center heals with gray-brown hyperpigmentation while the edge keeps advancing, producing fresh blisters and "migrating" into nearby skin.
- Mucosal Involvement: a bright red, inflamed tongue (glossitis), angular cheilitis and persistent conjunctivitis.
- The Clinical Tetrad of Glucagonoma Syndrome (the 4D Syndrome):
- Dermatosis: necrolytic migratory erythema (NME).
- Diabetes: mild to moderate diabetes, because glucagon opposes the action of insulin.
- DVT (deep vein thrombosis): deep vein thrombosis and pulmonary embolism, which carry a high risk of death.
- Depression: depression, mental changes and marked catabolic weight loss.
NME vs. Acrodermatitis Enteropathica vs. Autoimmune Pemphigus
| Necrolytic Migratory Erythema (NME) | Acrodermatitis Enteropathica | Pemphigus Foliaceus / Pemphigus Vulgaris |
|---|---|---|
| Pancreatic glucagon-secreting tumor (glucagonoma) | Inherited zinc deficiency (SLC39A4 gene) or dietary deficiency | Autoantibodies against desmoglein 1 / desmoglein 3 |
| Very high blood glucagon; zinc may be slightly low | Normal glucagon; very low blood zinc | Glucagon and zinc completely normal |
| Migrating necrotic red patches that heal centrally and flare at the edge | Peeling red rash around body openings and on the hands and feet | Shallow blisters that rupture into scaly crusts / mucosal erosions |
| Diabetes, weight loss, thrombosis (DVT), pancreatic tumor | Chronic diarrhea, hair loss, poor growth in children | No association with endocrine tumors or diabetes |
| No response, or only slight, temporary improvement | Rapid improvement with oral zinc | No response to zinc (needs corticosteroids/biologics) |
Diagnosis and Clinical Management at Haute-Derma
When we see a patient with a stubborn, migrating necrotic rash, Haute-Derma starts a full assessment:
Dermoscopy and Skin Biopsy
- Digital dermoscopy: shows central epidermal necrosis with gray-brown crust, a moist red border, and dotted or linear superficial dermal vessels.
- Skin biopsy (the key confirmatory test): shows necrolysis of the upper spinous layer (superficial epidermal necrolysis), spongiosis and neutrophils collecting in the upper epidermis, the classic picture of NME.
Invasive Cosmetic Procedures Are Contraindicated
- No laser or chemical peels: laser, chemical peels and microneedling must never be used on skin affected by NME. Injuring this skin can cause extensive necrosis, secondary infection and a severe Koebner-type flare.
- Symptomatic care: gentle hypochlorous acid (HOCl) antiseptic solutions, a barrier moisturizer with ceramides in a 3:1:1 ratio, and oral zinc and amino acid supplements while specialist test results are pending.
Urgent Referral for Pancreatic and Endocrine Workup
The patient is referred urgently to a leading oncology and endocrinology center for:
- Specialized blood tests: fasting plasma glucagon (diagnostic above 500 pg/mL), insulin and chromogranin A (CgA).
- Pancreatic tumor imaging: multidetector abdominal CT, MRI or somatostatin receptor imaging (somatostatin receptor scintigraphy/Octreoscan or gallium-68 DOTATATE PET-CT) to locate the glucagonoma in the tail of the pancreas and any liver metastases.